A 53-year-old woman is the first patient enrolled in Geisinger’s pilot program, which the system intends to expand. Under the program, the patient underwent total hip replacement surgery Feb. 26, and any future surgical care and costs related to the surgery will be covered by Geisinger and Medacta International, a global orthopedic medical device manufacturer.
“Rather than follow the prevalent fee-for-service model, Geisinger rewards value,” said Michael Suk, MD, chair of the Geisinger Musculoskeletal Institute and the Department of Orthopaedic Surgery. “When it comes to the hip replacement pilot program, what we’re saying to our patients is that the level of service we’ll provide will be so exemplary that if there’s a problem tomorrow or 20, 30, or 40 years from now, we’ll take care of it.”
Geisinger and Medacta International will share potential costs, including the medical device replacement and hospital costs, as long as the patient stays a Geisinger Health Plan member and sees Geisinger providers.
More articles on finance:
Baylor Scott & White closes 113-bed Texas hospital: 4 things to know
Tenet eliminates poison pill, adopts governance changes
94-year-old California hospital on active earthquake fault to close: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
